支气管肺炎患者的临床治疗体会

Clinical Treatment Experience of Patients With Bronchopneumonia

目的：探究支气管肺炎患者的治疗方法和效果。方法选取2013年4月～2014年7月收治的34例支气管肺炎患者进行治疗，随机分组，实验组19例患者选择布地奈德和氨溴索的综合治疗，对照组15例患者选择常规处理，对比患者身体的改善效果。结果实验组治疗有效率为94.74％，对照组治疗有效率为73.33％。治疗有效率两组患者的治疗效果差异有统计学意义（P〈0.05）。结论支气管肺炎患者采用布地奈德和氨溴索的综合治疗，能够及时改善症状，提高效果和患者的生活质量。

Objective To explore the treatment approach and effect in patients with bronchopneumonia. Methods Chose 34 bronchopneumonia patients who were treated in hospital from April 2013 to July 2014 and separate them into study group and control group at random. 19 patients in study group were given comprehensive treatment of budesonide and ambroxol,while 15 patients in control group were given conventional medication treatment,and then compare physical improvements between two groups. Results The result showed that treatment efficacy in study group was up to 94.74%, while treatment efficacy in control group was 73.33%. There was a differential between two groups in terms of physical improvements（P〈0.05）. Conclusion Comprehensive treatment of budesonide and ambroxol is of clinicial efficiency in treatment of bronchopneumonia patients. It is conducive to improving patients’quality of life.